EMILY MONNETTE: Open Payments
NPI 1457713075 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,461 in 97 payments from 18 companies in 2025. Trend: 2023 $1,489 · 2024 $2,341 · 2025 $1,461
Food & beverage: $1,461
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $301 |
| AstraZeneca Pharmaceuticals LP | 11 | $247 |
| Novo Nordisk Inc | 11 | $201 |
| Axsome Therapeutics, Inc. | 13 | $193 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $102 |
| PFIZER INC. | 4 | $80 |
| Lundbeck LLC | 3 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Lilly USA, LLC | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
Products named: VRAYLAR, Auvelity, AIRSUPRA, CAPLYTA, REXULTI, NURTEC ODT, Wegovy, FARXIGA.
Industry payments across TN — which companies pay providers there.
